Back to News
Market Impact: 0.3
Mesoblast Limited Reports first quarter FY2027 Activity with 44% increase in net revenues
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Mesoblast reported a 44% increase in net revenues and an 86% improvement in net operational cash spend for the fiscal quarter ended September 30, 2026, versus the prior-year period. The article text is truncated before the RYONCIL revenue figure, so that detail cannot be assessed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
MESO0.55
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations
- Taiwan Stocks Heads for Correction as Global AI Selloff Deepens